Safety and Tolerability of Glatiramer Acetate
Clinical trial NCT01874145 · COMPLETED
Trial details
- NCT number
- NCT01874145
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-04-01
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.